Battery-powered analysers are bringing anaemia, diabetes and TB tests to the village level. The development is being closely watched across the medtech & devices ecosystem, where executives say decisions made over the next two quarters will shape budgets well into 2028.
People familiar with the matter told Health Insider that the shift has been building for months, driven by rising costs, tighter regulatory scrutiny and a growing expectation from patients and payers that providers demonstrate measurable outcomes.
Why it matters
For hospital leaders, the change touches procurement, clinical workflows and how performance is reported to boards. For investors, it signals where the next wave of capital is likely to flow. And for patients, the impact will be felt in access, waiting times and out-of-pocket costs.
“Healthcare in India is moving from volume to value faster than most people expected. The organisations that measure what matters will pull ahead.”
What happens next
- Industry bodies are expected to submit recommendations in the coming weeks.
- Early adopters will publish their first results by the end of the financial year.
- Smaller providers are seeking a longer transition window.
Health Insider will continue to track the story. Readers with information can reach the newsroom confidentially through the contact page.
Conversation(0)
Community guidelinesNo comments yet. Start the conversation.